Browse the evidence

Metabolomic biomarkers, particularly Branched-Chain Amino Acids (BCAAs), aromatic amino acids, and specific lipids (ceramides, sphingomyelins), can predict the onset and progression of Metabolic Syndrome and Type 2 Diabetes before clinical symptoms appear.

Current standard blood tests may miss early metabolic dysfunction. Emerging research shows that specific amino acids and lipids rise before diabetes symptoms appear. Until these tests are routine, focus on early lifestyle changes if you have risk factors like central obesity.

In middle-aged men without prior cardiovascular disease or diabetes, total intake and specific types of dietary fat (saturated, monounsaturated, polyunsaturated, trans) and dietary cholesterol are not associated with the risk of ischaemic or haemorrhagic stroke.

For men without existing heart disease or diabetes, current evidence from this large study suggests that you do not need to strictly restrict total fat, saturated fat, or cholesterol intake specifically to prevent stroke. Focus on a balanced diet rather than fearing specific fat types for stroke prevention.

Caloric restriction enhances skeletal muscle insulin sensitivity in mice by activating Sirt1, which deacetylates and inactivates Stat3, thereby reducing the expression of inhibitory PI3K regulatory subunits (p55α/p50α) and improving PI3K signaling efficiency.

Caloric restriction improves how your muscles respond to insulin by activating a specific protein (Sirt1) that optimizes the cell's internal signaling machinery. This happens regardless of muscle mass changes and is driven by the energy deficit itself, likely through changes in cellular energy sensors (NAD+ levels).

There is a hormetic curve for NRF-2 activation: low-level activation extends lifespan, while high-level activation (e.g., via Keap1 deletion combined with lithium) shortens lifespan or provides no additional longevity benefit, though it increases stress resistance.

This study highlights a critical nuance in longevity pharmacology: NRF-2 activation must be carefully titrated. While low-level activation (via low-dose lithium) extends lifespan, excessive activation (mimicking strong stress responses) can shorten it. This suggests that future anti-aging drugs targeting NRF-2 must be precisely dosed to stay within the 'hormetic zone' of benefit, avoiding the toxic zone of over-activation.

Activation of mTORC1 via PKA phosphorylation of RAPTOR is an essential mechanism for β-adrenergic stimulation of adipose browning and UCP1 expression.

This research identifies a specific molecular pathway (PKA -> mTORC1 -> S6K1) required for your body to create 'beige fat' in response to cold or exercise. While you cannot directly 'dose' this pathway, understanding that mTORC1 is not just for storage but also for adaptive thermogenesis suggests that strategies promoting sympathetic activation (like cold exposure) rely on this pathway. Inhibiting mTOR chronically (as some longevity protocols do) might inadvertently blunt this adaptive fat-burning mechanism.

Mature white adipocytes can undergo bidirectional transdifferentiation into brite (brown-in-white) adipocytes in response to cold exposure, allowing the body to adjust the ratio of lipid-storing to lipid-burning cells within existing fat depots without requiring new cell differentiation from precursors.

This research suggests that your body's fat cells are not permanently stuck as 'storage' units. Exposure to cold can trigger existing white fat cells to become 'brite' cells that burn energy. While this doesn't replace diet and exercise, it highlights that metabolic flexibility exists and can potentially be influenced by environmental factors like cold exposure to support energy expenditure.

Iodine supplementation during preconception, pregnancy, and postpartum periods corrects maternal iodine insufficiency but shows no significant benefit for preventing preterm birth, low birthweight, or improving child neurodevelopment.

If you are pregnant or planning pregnancy, iodine supplementation is recommended to correct iodine deficiency, which is common. However, do not expect this supplementation to prevent preterm birth, low birth weight, or significantly boost your child's intelligence or motor development beyond what is achieved by correcting the deficiency. Stick to recommended prenatal doses.

Circadian misalignment induces a gene expression profile in skeletal muscle that favors fatty acid metabolism over glucose metabolism, potentially leading to substrate competition and reduced insulin sensitivity.

Your muscles change how they use fuel based on your schedule. When you are misaligned (e.g., working nights), your muscles switch to burning more fat and less glucose, which can interfere with insulin's ability to store glucose. This is driven by changes in gene expression. Maintaining a consistent schedule helps keep your muscle metabolism balanced.

In rodents, resistin is an adipokine that directly causes insulin resistance and impairs glucose tolerance, whereas in humans, resistin is primarily secreted by macrophages and serves as a marker of inflammation rather than a direct cause of insulin resistance.

While resistin levels are elevated in obesity and correlate with insulin resistance, human biology differs from rodents. In humans, resistin is largely a marker of inflammation (from macrophages) rather than a direct driver of insulin resistance from fat cells. Managing inflammation and metabolic health requires a holistic approach, not just targeting this single biomarker.

Elevated resistin levels are predictive of atherosclerosis, coronary artery disease (CAD), and adverse cardiovascular outcomes in humans, independent of traditional risk factors like CRP.

High resistin levels are associated with a higher risk of heart disease and stroke. While not a standalone diagnostic tool, it reflects underlying inflammation and vascular stress. Focus on proven cardiovascular health strategies: manage blood pressure, lipids, blood sugar, and avoid smoking.

Dietary nitrate supplementation does not improve performance in highly trained endurance athletes during cycling or running, likely due to higher baseline nitric oxide bioavailability.

If you are an elite endurance athlete, stop wasting money on beetroot juice for running or cycling; it won't help you. Focus on training.

Hepatic lipid accumulation acts as a primary driver of systemic metabolic dysfunction by serving as ligands for PPARs, which upregulate gluconeogenic, lipogenic, and ketogenic genes, thereby promoting hyperglycemia and hyperlipidemia.

If you have fatty liver, your liver is actively contributing to your metabolic issues (like high blood sugar) by sending chemical signals that tell your body to produce more glucose and store more fat. Treating the fatty liver is not just about removing fat; it is about stopping these active signals that drive systemic disease.

The typical hormonal environment in fatty liver disease—hyperinsulinemia, hyperglucagonemia, hypercortisolemia, and growth hormone deficiency—synergistically encourages further hepatic steatosis by dysregulating adipose lipolysis and hepatic lipid handling.

Your body's hormone levels (insulin, cortisol, glucagon) are not just bystanders in fatty liver; they actively drive more fat into the liver. Addressing insulin resistance and stress is key to breaking this cycle.

Fructose consumption promotes hepatic de novo lipogenesis (DNL) and NAFLD development through both substrate provision and independent upregulation of lipogenic transcription factors (SREBP1c and ChREBP), even in the absence of insulin signaling.

High amounts of fructose (especially from added sugars or juices) directly stimulate your liver to make new fat, even if you aren't insulin resistant. This process is unique to fructose compared to glucose.

The presence of functional p53 is required for maximal aerobic exercise capacity and the training-induced increase in skeletal muscle mitochondrial DNA content via the regulation of TFAM transcription.

Maximal aerobic endurance relies heavily on the integrity of your cellular machinery (mitochondria). While you might maintain high-intensity sprinting ability, your ability to sustain long-duration effort is a specific biological trait. For optimal cardiovascular health, prioritize sustained aerobic training, as this drives the mitochondrial adaptations (via p53/TFAM pathways) that protect against mortality.

p53 regulates skeletal muscle mitochondrial DNA (mtDNA) content by directly interacting with and transactivating the Mitochondrial Transcription Factor A (TFAM) gene.

Mitochondrial density in your muscles is genetically regulated by how well your body manages stress responses (p53) and builds mitochondrial machinery (TFAM). This suggests that endurance training benefits are partly dependent on your genetic ability to upregulate these specific mitochondrial genes.

Loss of circulating estrogen (E2) due to menopause causes rapid metabolic changes, including reduced metabolic rate, increased central adiposity, and insulin resistance, primarily mediated by estrogen receptor alpha (ERα).

If you are postmenopausal, the drop in estrogen is a major factor in gaining belly fat and developing insulin resistance. While hormone replacement therapy (HRT) can significantly lower diabetes risk, it must be weighed against potential cancer risks. Discuss with your doctor if tissue-selective estrogen complexes (TSECs) or early intervention might be appropriate for your metabolic health.

Estrogen receptor alpha (ERα) activation improves insulin sensitivity and glucose tolerance, whereas ERβ activation may have prodiabetogenic effects or reduced efficacy in this context.

Not all estrogen effects are the same. The specific receptor alpha (ERα) is key for improving insulin sensitivity. This suggests that future treatments might focus on targeting this specific receptor to gain metabolic benefits while avoiding other side effects.

Estrogen regulates mitochondrial function, including biogenesis and respiratory chain activity, and loss of estrogen leads to mitochondrial dysfunction which contributes to insulin resistance.

Estrogen helps your cells produce energy efficiently. After menopause, the drop in estrogen can impair your mitochondria, leading to fatigue and weight gain. This is one reason why metabolic rate slows down after menopause.

FTO gene variants are associated with increased energy intake rather than energy expenditure, leading to a 3-4 kg higher body weight and 1.67-fold increased obesity risk in homozygotes.

If you have the FTO risk variant, be aware that you may have a genetic predisposition to eat more. Focus on managing energy intake through mindful eating strategies.

Higher levels of dispositional optimism are associated with a longer life span and greater odds of achieving exceptional longevity (survival to age 85+), independent of demographics, health conditions, and health behaviors.

Cultivating a realistic positive outlook on the future is associated with living significantly longer. This is not about ignoring reality, but about maintaining confidence in your ability to handle challenges. This trait is linked to healthier behaviors like better diet and exercise, which drive the longevity benefit. Since optimism can be learned, engaging in practices that build resilience and positive goal-setting may support a longer life.

Both resistin and visfatin act as pro-inflammatory mediators that contribute to chronic inflammatory diseases, including rheumatoid arthritis, atherosclerosis, and inflammatory bowel disease, by stimulating cytokine production and immune cell activation.

Resistin and visfatin are hormones that promote inflammation, which is linked to many chronic diseases. Reducing inflammation through diet and lifestyle may help manage these hormone levels and improve health outcomes in conditions like arthritis and heart disease.

Men with type 2 diabetes exhibit specific insulin resistance in protein metabolism, characterized by a failure of protein synthesis to increase in response to hyperinsulinemia, whereas women with type 2 diabetes do not show this additive resistance beyond that caused by obesity alone.

If you have type 2 diabetes, your body's ability to use insulin to build muscle (protein synthesis) is specifically impaired, particularly if you are male. This isn't just about blood sugar; it's about how your muscles respond to food. Women with T2D may not share this specific synthesis resistance to the same degree as men. This suggests that protein intake strategies might need to be tailored by sex and diabetes status, rather than following a generic 'high protein' rule.

Treatment with PPAR-gamma agonists (thiazolidinediones) increases circulating adiponectin levels, which may mediate their insulin-sensitizing effects.

Thiazolidinediones, a class of diabetes medications, work in part by increasing levels of the hormone adiponectin. This increase in adiponectin helps improve insulin sensitivity. If you are considering medication for diabetes, discuss with your doctor how these drugs might affect your hormonal balance and metabolic health.